CYP2C19 Genotype‐Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure
ABSTRACT In neurovascular settings, including treatment and prevention of ischemic stroke and prevention of thromboembolic complications after percutaneous neurointerventional procedures, dual antiplatelet therapy with a P2Y12 inhibitor and aspirin is the standard of care. Clopidogrel remains the mo...
Saved in:
Main Authors: | Kayla R. Tunehag, Ashton F. Pearce, Layna P. Fox, George A. Stouffer, Sten Solander, Craig R. Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Science |
Subjects: | |
Online Access: | https://doi.org/10.1111/cts.70131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia
by: Robert H. Lee, et al.
Published: (2025-01-01) -
Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
by: Asmaa Ibrahim, et al.
Published: (2025-02-01) -
Comparative bioavailability of two oral formulations of clopidogrel: Determination of clopidogrel and its carboxylic acid metabolite (SR26334) under fasting and fed conditions in healthy subjects
by: Brvar Nina, et al.
Published: (2014-03-01) -
Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01) -
Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01)